Back to Top
Go Back
Journal Photo for Molecular Therapy
Peer reviewed only Open Access

Molecular Therapy (MT)

Publisher : Cell Press
Pharmacology Pharmaceutics Drug Discovery
Claim Your Journal Get PRC Visit Website
e-ISSN 1525-0024
p-ISSN 1525-0016
Issue Frequency Monthly
Impact Factor 12.1
Est. Year 2000
Mobile 16173972800
Country United States
Language English
APC YES
Impact Factor Assignee Google Scholar
Email press@cell.com

Journal Descriptions

Molecular Therapy is the leading journal for research in the areas of gene transfer, vector development and design, stem cell manipulation, development of gene-, peptide-, protein-, oligonucleotide-, and cell-based therapeutics to correct genetic and acquired diseases, vaccine development, pre-clinical target validation, safety/efficacy studies, and clinical trials. Molecular Therapy is dedicated to promoting the sciences in genetics, medicine, and biotechnology. Publishing important peer-reviewed research and cutting-edge reviews and commentaries, the journal continues to attract the best material in the field. Molecular Therapy's 2022 impact factor is 12.4.

Molecular Therapy (MT) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Pharmacology, Pharmaceutics, Drug Discovery, Genetics, Molecular Biology, Molecular Medicine , Online or Print , Monthly Journal

  • UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1525-0016, E-ISSN: 1525-0024, Established: 2000, Impact Factor: 12.1
  • Does Not Provide Crossref DOI

  • Indexed in: Scopus

  • Not indexed in WoS, DOAJ, PubMed, UGC CARE

Indexing